SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001178913-23-003834
Filing Date
2023-12-04
Accepted
2023-12-04 06:01:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A zk2330614.htm SC 13D/A 59879
  Complete submission text file 0001178913-23-003834.txt   61162
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87931 | Film No.: 231461187
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6 HACHOSHLIM ST. HERZELIA L3 4672406
Business Address
Arkin Moshe (Filed by) CIK: 0001321178 (see all company filings)

Type: SC 13D/A